PortfoliosLab logoPortfoliosLab logo
VIR vs. CHRW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VIR vs. CHRW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vir Biotechnology, Inc. (VIR) and C.H. Robinson Worldwide, Inc. (CHRW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VIR achieves a 43.62% return, which is significantly higher than CHRW's -7.48% return.


VIR

1D
-2.70%
1M
-13.75%
6M
16.40%
YTD
43.62%
1Y
72.17%
3Y*
-15.28%
5Y*
-24.65%
10Y*
ALL TIME*
-8.75%

CHRW

1D
0.55%
1M
-22.19%
6M
-23.70%
YTD
-7.48%
1Y
31.80%
3Y*
16.80%
5Y*
13.19%
10Y*
10.53%
ALL TIME*
13.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$526.07M$418.85M$344.02M
$13.61M$14.70M$17.41M

VIR vs. CHRW - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
VIR
Vir Biotechnology, Inc.
43.62%-17.85%-27.04%-60.25%-39.55%56.35%112.96%-22.14%
CHRW
C.H. Robinson Worldwide, Inc.
-7.48%59.01%22.89%-3.10%-13.09%17.22%22.95%-6.66%

Correlation

The correlation between VIR and CHRW is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.02

Correlation (3Y)
Balances recent behavior with more history.

0.14

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.15

Correlation (All Time)
Calculated using the full available price history since Oct 11, 2019

0.13

The correlation between VIR and CHRW shifts across timeframes, from 0.02 (1 year) to 0.15 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VIR:

$1.46B

CHRW:

$17.41B

EPS

VIR:

-$3.12

CHRW:

$5.23

PS Ratio

VIR:

18.75

CHRW:

1.05

PB Ratio

VIR:

1.57

CHRW:

10.92

Total Revenue (TTM)

VIR:

$65.50M

CHRW:

$17.00B

Gross Profit (TTM)

VIR:

$183.11M

CHRW:

$676.81M

EBITDA (TTM)

VIR:

-$448.10M

CHRW:

$909.95M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VIR vs. CHRW — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VIR
VIR Risk / Return Rank: 7979
Overall Rank
VIR Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
VIR Sortino Ratio Rank: 7878
Sortino Ratio Rank
VIR Omega Ratio Rank: 7474
Omega Ratio Rank
VIR Calmar Ratio Rank: 8585
Calmar Ratio Rank
VIR Martin Ratio Rank: 8383
Martin Ratio Rank

CHRW
CHRW Risk / Return Rank: 6868
Overall Rank
CHRW Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
CHRW Sortino Ratio Rank: 6363
Sortino Ratio Rank
CHRW Omega Ratio Rank: 6969
Omega Ratio Rank
CHRW Calmar Ratio Rank: 6767
Calmar Ratio Rank
CHRW Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VIR vs. CHRW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and C.H. Robinson Worldwide, Inc. (CHRW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VIRCHRWDifference
Sharpe ratioReturn per unit of total volatility

+0.33

Sortino ratioReturn per unit of downside risk

+0.74

Omega ratioGain probability vs. loss probability

1.22

1.19

+0.03

Calmar ratioReturn relative to maximum drawdown

2.78

1.01

+1.77

Martin ratioReturn relative to average drawdown

6.37

3.56

+2.81

VIR vs. CHRW - Sharpe Ratio Comparison

The current VIR Sharpe Ratio is 1.03, which is higher than the CHRW Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of VIR and CHRW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VIR vs. CHRW - Drawdown Comparison

The maximum VIR drawdown since its inception was -94.85%, which is greater than CHRW's maximum drawdown of -44.54%. Use the drawdown chart below to compare losses from any high point for VIR and CHRW.


Loading charts...

Drawdown Indicators


VIRCHRWDifference

Max Drawdown

Largest peak-to-trough decline

-94.85%

-44.54%

-50.31%

Max Drawdown (1Y)

Largest decline over 1 year

-25.61%

-29.84%

+4.23%

Max Drawdown (3Y)

Largest decline over 3 years

-68.58%

-30.59%

-37.99%

Max Drawdown (5Y)

Largest decline over 5 years

-92.15%

-40.55%

-51.60%

Max Drawdown (10Y)

Largest decline over 10 years

-40.55%

Current Drawdown

Current decline from peak

-89.58%

-29.46%

-60.12%

Average Drawdown

Average peak-to-trough decline

-68.14%

-12.06%

-56.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.16%

8.49%

+2.67%

Volatility

VIR vs. CHRW - Volatility Comparison

The current volatility for Vir Biotechnology, Inc. (VIR) is 12.38%, while C.H. Robinson Worldwide, Inc. (CHRW) has a volatility of 21.50%. This indicates that VIR experiences smaller price fluctuations and is considered to be less risky than CHRW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VIRCHRWDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.38%

21.50%

-9.12%

Volatility (6M)

Calculated over the trailing 6-month period

45.20%

36.66%

+8.54%

Volatility (1Y)

Calculated over the trailing 1-year period

69.13%

46.91%

+22.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.66%

33.69%

+38.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.40%

29.60%

+65.80%

Dividends

VIR vs. CHRW - Dividend Comparison

VIR has not paid dividends to shareholders, while CHRW's dividend yield for the trailing twelve months is around 1.70%.


PositionTTM20252024202320222021202020192018201720162015
CHRW
C.H. Robinson Worldwide, Inc.
1.70%1.55%2.38%2.82%2.47%1.93%2.17%2.57%2.24%2.03%2.38%2.53%
VIR
Vir Biotechnology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

VIR vs. CHRW - Financials Comparison

This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and C.H. Robinson Worldwide, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


VIR and CHRW have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CHRW has higher volatility (21.50%) compared to VIR (12.38%). In terms of maximum drawdown, VIR dropped -94.85% vs CHRW's -44.54%.

VIR currently has the higher Sharpe Ratio (1.03 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VIR and CHRW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer